Trump Nominee Marty Makary Faces Senate Scrutiny for FDA Leadership

Makary's confirmation hearing highlights challenges of FDA reform, political pressures, and vaccine policy debates.

Marty Makary, a Johns Hopkins surgeon and author, is President Trump's nominee for FDA commissioner and will face Senate questioning today.
Makary's nomination comes during a turbulent period for the FDA, marked by recent mass layoffs, resignations, and potential budget cuts under the Trump administration.
Health Secretary Robert F. Kennedy Jr.'s controversial proposals, including reevaluating vaccine safety and FDA practices, have raised concerns about the agency's future direction.
Makary is known for his critiques of the medical establishment and FDA bureaucracy but is considered a well-qualified and conventional choice compared to other Trump health appointees.
Senate Democrats are expected to press Makary on his stance on vaccine policy, including his willingness to challenge Kennedy's skepticism about established public health measures.